-
A Brooklyn, NY, resident presented in early June with a one-week history of fever, headaches, left-sided pleuritic chest pain, and a pleural effusion.
-
-
In This Issue: Baxter Bioscience has developed a whole-virus, two dose vaccine against avian flu; warning label now on antipsychotics regarding an increased risk of mortality in elderly patients treated for dementia-related psychosis; vitamin D for men with heart disease on horizon? A new oral anticoagulant may soon be available for prevention of thrombotic complications of hip or knee surgery; FDA Actions
-
In the absence of any randomized clinical trial data, clinicians aren't exactly sure when it makes good sense to order magnetic resonance imaging (MRI) prior to breast cancer surgery and when it is more likely to offer little benefit.
-
Could whole milk work just as well as the more expensive, barium-based contrast agents for imaging of the gastrointestinal tract?
-
In the next few months, researchers at the University of California at Los Angeles' (UCLA's) Jonsson Comprehensive Cancer Center will begin human studies on a new probe for Positron Emission Tomography (PET) that they believe will provide clinicians and researchers with a powerful new window on the immune system, as well as enable them to gauge early patient response to therapies.
-
The Food and Drug Administration (FDA) has sent an alert about X-rays used during CT examinations that might cause implanted and external electronic medical devices to malfunction.
-
Powerful new evidence has emerged demonstrating the benefits of radiotherapy in prostate cancer patients following radical prostatectomy.
-
It's great to be armed with scientific evidence, but it does no good if the patients who could benefit from this evidence are not referred to you for care.
-
It's unpleasant enough to receive a diagnosis of prostate cancer and to face a course of radiotherapy that can cause a number of side effects, ranging from incontinence to a loss of potency.
